Screener
Neuropace, Inc. NPCE Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s operating margin?
- Neuropace, Inc. (NPCE) reported operating margin of -15.3% in Q2 2026.
- How has Neuropace, Inc.'s operating margin changed year-over-year?
- Neuropace, Inc.'s operating margin increased by 39.2% year-over-year, from -25.1% to -15.3%.
- What is the long-term trend for Neuropace, Inc.'s operating margin?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s operating margin has grown at a -10.3% compound annual growth rate (CAGR), from -31.7% to -18.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Neuropace, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude